These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 8732602

  • 1. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
    Asante-Korang A, Boyle GJ, Webber SA, Miller SA, Fricker FJ.
    J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
    [Abstract] [Full Text] [Related]

  • 2. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 3. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 4. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 5. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL.
    Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 7. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 8. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z, Abbas S, Moore E, Diallo O, Hauptman PJ, Bastani B.
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [Abstract] [Full Text] [Related]

  • 9. Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients.
    O'Gorman MA, Fivush B, Wise B, Colombani P, Burdick J, Schwarz KB.
    Clin Transplant; 1995 Aug; 9(4):312-6. PubMed ID: 7579739
    [Abstract] [Full Text] [Related]

  • 10. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
    J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of long-term immunosuppressive therapy in Chinese pediatric renal transplant patients: a single-center experience.
    Yang S, Wu Z, Wu W, Lin W, Xu T, Cai J, Wang Q, Liao L, Tan J.
    Transplant Proc; 2009 Dec; 41(10):4169-71. PubMed ID: 20005361
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T, CRAF Study Group.
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [Abstract] [Full Text] [Related]

  • 13. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW, Ketel BL, Abul-Ezz SR, Lightfoot ML.
    JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
    [Abstract] [Full Text] [Related]

  • 14. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 15. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J, Jalanko H, Leijala M, Sairanen H, Holmberg C.
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [Abstract] [Full Text] [Related]

  • 16. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [Abstract] [Full Text] [Related]

  • 17. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG, Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [Abstract] [Full Text] [Related]

  • 18. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 19. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function.
    Garrido IP, Crespo-Leiro MG, Paniagua MJ, Muñiz J, Vázquez-Rey E, Pérez-Fernández R, García-Lara J, Cuenca-Castillo JJ, Castro-Beiras A.
    J Heart Lung Transplant; 2005 Sep; 24(9):1226-30. PubMed ID: 16143237
    [Abstract] [Full Text] [Related]

  • 20. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.